Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

Takeda/Otsuka bolster GI presence via Japan P-CAB alliance

28.03.2014 / Scripintelligence

The tie-up will play to the strengths of both partners in the gastrointestinal area in Japan, where Otsuka markets the protective anti-ulcer agent Mucosta (rebamipide) and Takeda's Takepron (lansoprazole) is a leading PPI; however, both drugs are facing…

Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: